rs141875736
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 3P and 16B. PM1PM4_SupportingBP6_Very_StrongBA1
The NM_032193.4(RNASEH2C):c.268_270delAAG(p.Lys90del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,614,274 control chromosomes in the GnomAD database, including 354 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0039 ( 308 hom. )
Consequence
RNASEH2C
NM_032193.4 conservative_inframe_deletion
NM_032193.4 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.855
Genes affected
RNASEH2C (HGNC:24116): (ribonuclease H2 subunit C) This gene encodes a ribonuclease H subunit that can cleave ribonucleotides from RNA:DNA duplexes. Mutations in this gene cause Aicardi-Goutieres syndrome-3, a disease that causes severe neurologic dysfunction. A pseudogene for this gene has been identified on chromosome Y, near the sex determining region Y (SRY) gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
PM1
In a chain Ribonuclease H2 subunit C (size 163) in uniprot entity RNH2C_HUMAN there are 16 pathogenic changes around while only 2 benign (89%) in NM_032193.4
PM4
Nonframeshift variant in NON repetitive region in NM_032193.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 11-65720319-CCTT-C is Benign according to our data. Variant chr11-65720319-CCTT-C is described in ClinVar as [Likely_benign]. Clinvar id is 305363.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-65720319-CCTT-C is described in Lovd as [Benign]. Variant chr11-65720319-CCTT-C is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASEH2C | NM_032193.4 | c.268_270delAAG | p.Lys90del | conservative_inframe_deletion | 2/4 | ENST00000308418.10 | NP_115569.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASEH2C | ENST00000308418.10 | c.268_270delAAG | p.Lys90del | conservative_inframe_deletion | 2/4 | 1 | NM_032193.4 | ENSP00000308193.5 |
Frequencies
GnomAD3 genomes AF: 0.00512 AC: 779AN: 152266Hom.: 46 Cov.: 32
GnomAD3 genomes
AF:
AC:
779
AN:
152266
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0108 AC: 2727AN: 251488Hom.: 206 AF XY: 0.00983 AC XY: 1336AN XY: 135918
GnomAD3 exomes
AF:
AC:
2727
AN:
251488
Hom.:
AF XY:
AC XY:
1336
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00392 AC: 5733AN: 1461890Hom.: 308 AF XY: 0.00385 AC XY: 2797AN XY: 727244
GnomAD4 exome
AF:
AC:
5733
AN:
1461890
Hom.:
AF XY:
AC XY:
2797
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00510 AC: 777AN: 152384Hom.: 46 Cov.: 32 AF XY: 0.00609 AC XY: 454AN XY: 74510
GnomAD4 genome
AF:
AC:
777
AN:
152384
Hom.:
Cov.:
32
AF XY:
AC XY:
454
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
142
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Aicardi-Goutieres syndrome 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 22, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 15, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Aicardi Goutieres syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at